Published in J Child Neurol on November 01, 1999
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder. Neurology (2008) 0.96
Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. J Neurol Neurosurg Psychiatry (2007) 0.84
Vacuolar leucoencephalopathy and pulvinar sign in association with coeliac disease. BMJ Case Rep (2009) 0.77
Dystonic reactions in children caused by metoclopramide. Arch Dis Child (1970) 4.80
The frequency of lysosomal storage diseases in The Netherlands. Hum Genet (1999) 3.54
Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett (1995) 2.64
Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene. Am J Hum Genet (1998) 2.62
Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet (1997) 2.30
Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr (1998) 2.26
Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. Radiology (1999) 2.24
Novel mutations in the connexin 26 gene (GJB2) responsible for childhood deafness in the Japanese population. Am J Med Genet (2000) 2.17
X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. Am J Hum Genet (2001) 1.95
Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses. Clin Chem (1989) 1.91
A new leukoencephalopathy with vanishing white matter. Neurology (1997) 1.90
Performance of near-infrared spectroscopy in measuring local O(2) consumption and blood flow in skeletal muscle. J Appl Physiol (1985) (2001) 1.86
Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta (1984) 1.83
Cobblestone-like brain dysgenesis and altered glycosylation in congenital cutis laxa, Debre type. Neurology (2008) 1.78
Defining the phenotype in an autosomal recessive cutis laxa syndrome with a combined congenital defect of glycosylation. Eur J Hum Genet (2007) 1.76
Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosis. Brain (2000) 1.75
A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol (1993) 1.70
Sjögren-Larsson syndrome: clinical and MRI/MRS findings in FALDH-deficient patients. Neurology (1999) 1.67
Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet (1998) 1.66
Cerebrotendinous xanthomatosis: the spectrum of imaging findings and the correlation with neuropathologic findings. Radiology (2000) 1.63
Congenital myotonic dystrophy; a report on thirteen cases and a review of the literature. J Neurol Sci (1993) 1.63
Effect of enzyme therapy in juvenile patients with Pompe disease: a three-year open-label study. Neuromuscul Disord (2010) 1.62
An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids. Lancet (1984) 1.61
Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta (1992) 1.59
Genetic characteristics of myoadenylate deaminase deficiency. Ann Neurol (1998) 1.57
Endocrinology of the carbohydrate-deficient glycoprotein syndrome type 1 from birth through adolescence. Pediatr Res (1995) 1.52
Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Neurology (2012) 1.52
Vigabatrin in GABA metabolism disorders. Lancet (1989) 1.51
Idiopathic neuralgic amyotrophy in children. A distinct phenotype compared to the adult form. Neuropediatrics (2000) 1.50
Inherited disorders of GABA metabolism. J Inherit Metab Dis (1993) 1.50
Low cerebrospinal fluid concentration of free gamma-aminobutyric acid in startle disease. Lancet (1992) 1.49
Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49
Congenital muscular dystrophy. J Pediatr (1989) 1.48
D-penicillamine-induced IgA deficiency in Wilson's disease. Lancet (1976) 1.47
A mitochondrial encephalomyopathy: the first case with an established defect at the level of coenzyme Q. Eur J Pediatr (1986) 1.46
Mosaic 13 trisomy due to de novo 13/13 translocation with subsequent fission. Karyotype: 46,XX,-13, +t(13;13)(p11;q11)/46,XX,del(13)(p11). A second example. Ann Genet (1989) 1.46
Tyrosine hydroxylase deficiency with severe clinical course: clinical and biochemical investigations and optimization of therapy. J Pediatr (2000) 1.45
Is muscle glycogenolysis impaired in X-linked phosphorylase b kinase deficiency? Neurology (2008) 1.45
Adipose tissue thickness affects in vivo quantitative near-IR spectroscopy in human skeletal muscle. Clin Sci (Lond) (2001) 1.45
Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology (2012) 1.42
Proton nuclear magnetic resonance spectroscopy of body fluids in the field of inborn errors of metabolism. Ann Clin Biochem (2003) 1.42
Microheterogeneity of serum glycoproteins and their liver precursors in patients with carbohydrate-deficient glycoprotein syndrome type I: apparent deficiencies in clusterin and serum amyloid P. J Lab Clin Med (1997) 1.42
Ileus in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Neth J Med (1998) 1.42
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. Glycobiology (2001) 1.41
Familial adult-onset muscular dystrophy with leukoencephalopathy. Ann Neurol (1992) 1.40
Successful treatment of pure myopathy, associated with complex I deficiency, with riboflavin and carnitine. Arch Neurol (1991) 1.39
Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet (1996) 1.38
Structure, turnover, and heme-mediated suppression of the level of mRNA encoding rat liver delta-aminolevulinate synthase. J Biol Chem (1988) 1.38
Canavan disease: value of N-acetylaspartic aciduria? Neuropediatrics (1991) 1.38
Carbohydrate deficient serum transferrin in a new systemic hereditary syndrome. Arch Dis Child (1990) 1.38
Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis. Am J Ophthalmol (1991) 1.38
Pharmacokinetics of di-n-propylacetate in epileptic patients. Eur J Clin Pharmacol (1975) 1.35
Malformative syndrome associated with a ring 10 chromosome and a translocated 10q/19 chromosome. Hum Genet (1978) 1.34
Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue. Clin Chem (1992) 1.34
A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases. J Med Genet (2001) 1.34
Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest (2000) 1.33
A mutation in the human ortholog of the Saccharomyces cerevisiae ALG6 gene causes carbohydrate-deficient glycoprotein syndrome type-Ic. Proc Natl Acad Sci U S A (1999) 1.33
MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest (2001) 1.33
Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2. FEBS Lett (1999) 1.31
Xeroderma pigmentosum complementation group G associated with Cockayne syndrome. Am J Hum Genet (1993) 1.31
A new variant of the carbohydrate deficient glycoproteins syndrome. J Inherit Metab Dis (1991) 1.31
De-novo mutation in hereditary motor and sensory neuropathy type I. Lancet (1992) 1.30
4-Hydroxybutyric aciduria: application of a fluorometric assay to the determination of succinic semialdehyde dehydrogenase activity in extracts of cultured human lymphoblasts. Clin Chim Acta (1991) 1.29
Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inherit Metab Dis (1995) 1.28
Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology (2000) 1.28
The glycine cleavage system. Molecular cloning of the chicken and human glycine decarboxylase cDNAs and some characteristics involved in the deduced protein structures. J Biol Chem (1991) 1.27
Dopa-responsive dystonia: a clinical and molecular genetic study. Ann Neurol (1998) 1.25
Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroids. Neuroradiology (2005) 1.25
Geroderma osteodysplasticum hereditaria and wrinkly skin syndrome in 22 patients from Oman. Am J Med Genet A (2008) 1.23
Cerebellar ataxia and congenital disorder of glycosylation Ia (CDG-Ia) with normal routine CDG screening. J Neurol (2007) 1.23
Congenital disorder of glycosylation type Ix: review of clinical spectrum and diagnostic steps. J Inherit Metab Dis (2008) 1.23
Congenital folate malabsorption. Eur J Pediatr (1985) 1.22
Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect? Ann Neurol (2001) 1.22
Maternal occupational exposure during pregnancy and the risk of spina bifida. Occup Environ Med (1996) 1.22
Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A (2005) 1.21
Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism. Neuropediatrics (1984) 1.21
Ophthalmological abnormalities in children with congenital disorders of glycosylation type I. Br J Ophthalmol (2008) 1.21
An apparent homozygous X-linked disorder with carbohydrate-deficient serum glycoproteins. Lancet (1987) 1.21
Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet (1998) 1.20
Prenatal diagnosis in CDG1 families: beware of heterogeneity. Eur J Hum Genet (1998) 1.19
Ocular and systemic manifestations of cerebrotendinous xanthomatosis. Am J Ophthalmol (1995) 1.18
Clinical and genetic spectrum of Sanfilippo type C (MPS IIIC) disease in The Netherlands. Mol Genet Metab (2007) 1.18
Spinal xanthomatosis: a variant of cerebrotendinous xanthomatosis. Brain (1999) 1.17
L-2-hydroxyglutaric acidemia: a novel inherited neurometabolic disease. Ann Neurol (1992) 1.16
Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice. Gene Ther (2004) 1.13
X-linked creatine transporter defect: an overview. J Inherit Metab Dis (2003) 1.12
Leigh syndrome, a mitochondrial encephalo(myo)pathy. A review of the literature. Clin Neurol Neurosurg (1987) 1.12
A mutation in adenylosuccinate lyase associated with mental retardation and autistic features. Nat Genet (1992) 1.11
Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain (2001) 1.11
Mental retardation and behavioral problems as presenting signs of a creatine synthesis defect. Ann Neurol (2000) 1.11
Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology (2004) 1.10
Hypomyelination and reversible white matter attenuation in 3-phosphoglycerate dehydrogenase deficiency. Neuropediatrics (2000) 1.10
Intestinal permeability after severe trauma and hemorrhagic shock is increased without relation to septic complications. Arch Surg (1993) 1.10
Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency. Hum Genet (2001) 1.10
Treatment and follow-up of children with cerebrotendinous xanthomatosis. Eur J Pediatr (1998) 1.10
Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis. Ann Neurol (2000) 1.09